We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+5.24%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$463B
AUM Growth
+$17.5B
Cap. Flow
-$1.61B
Cap. Flow %
-0.35%
Top 10 Hldgs %
12.49%
Holding
2,596
New
97
Increased
1,091
Reduced
793
Closed
67

Sector Composition

Rank Sector Weight
1 Healthcare 16.64%
2 Consumer Discretionary 13.46%
3 Financials 12.79%
4 Industrials 12.13%
5 Technology 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INTU icon
801
Intuit
INTU
$98B
$60.5M 0.01%
751,721
-7,958
-1% -$614K
THOR
802
DELISTED
THORATEC CORPORATION
THOR
$60.4M 0.01%
1,732,673
-193,141
-10% -$6.44M
CAKE icon
803
Cheesecake Factory
CAKE
$5.57B
$60.3M 0.01%
1,299,060
+10,620
+0.8% +$489K
NLY icon
804
Annaly Capital Management
NLY
$17.6B
$60.2M 0.01%
1,315,932
-252,619
-16% -$11.6M
AEGN
805
DELISTED
Aegion Corp
AEGN
$59.9M 0.01%
2,576,210
-3,800
-0.1% -$90.3K
AIN icon
806
Albany International
AIN
$1.82B
$59.9M 0.01%
1,578,243
-75,970
-5% -$2.76M
CSLT
807
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$59.6M 0.01%
4,087,145
-126,000
-3% -$2.05M
QDEL icon
808
QuidelOrtho
QDEL
$1.03B
$59.5M 0.01%
2,690,990
+12,700
+0.5% +$292K
ADBE icon
809
Adobe
ADBE
$108B
$59.2M 0.01%
818,646
+19,942
+2% +$1.29M
LABL
810
DELISTED
Multi-Color Corp
LABL
$59.2M 0.01%
1,479,926
+105,961
+8% +$3.77M
HDB icon
811
HDFC Bank
HDB
$119B
$59.2M 0.01%
5,055,692
-14,336
-0.3% -$157K
CHSP
812
DELISTED
Chesapeake Lodging Trust
CHSP
$58.9M 0.01%
1,947,620
-16,660
-0.8% -$470K
PIPR icon
813
Piper Sandler
PIPR
$5.54B
$58.9M 0.01%
4,547,016
-19,920
-0.4% -$224K
CBSH icon
814
Commerce Bancshares
CBSH
$8.61B
$58.7M 0.01%
2,266,026
+3,233
+0.1% +$80K
BEN icon
815
Franklin Resources
BEN
$17.2B
$58.7M 0.01%
1,014,399
-2,191,089
-68% -$120M
KRFT
816
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
$57.8M 0.01%
964,547
+1,667
+0.2% +$96.5K
MORN icon
817
Morningstar
MORN
$7.76B
$57.8M 0.01%
805,044
-123,100
-13% -$9M
IMS
818
DELISTED
IMS HEALTH HLDGS INC COM STK (DE)
IMS
$57.8M 0.01%
+2,249,100
New +$54.1M
NILE
819
DELISTED
Blue Nile, Inc.
NILE
$57.6M 0.01%
2,055,621
-118,438
-5% -$3.73M
RDUS
820
DELISTED
Radius Recycling
RDUS
$57.2M 0.01%
2,194,770
+39,430
+2% +$1.05M
FNSR
821
DELISTED
Finisar Corp
FNSR
$57.1M 0.01%
2,891,027
-743,590
-20% -$17.9M
CBF
822
DELISTED
Capital Bank Financial Corp. Class A Common Stock
CBF
$57.1M 0.01%
2,418,060
-36,840
-2% -$892K
BNNY
823
DELISTED
ANNIES INC COMMON STOCK (DE)
BNNY
$57M 0.01%
1,683,915
+269,230
+19% +$9.05M
DATA
824
DELISTED
Tableau Software, Inc.
DATA
$56.9M 0.01%
797,119
+448,925
+129% +$28.1M
JJSF icon
825
J&J Snack Foods
JJSF
$1.7B
$56.6M 0.01%
601,821
+417,700
+227% +$39.3M

Similar funds

T. Rowe Price Associates's Q2 2014 Portfolio in Review

As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
  • T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
  • T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
  • T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
  • T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
  • T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
  • T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.

Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.